Showing results (61-70 of 132) with videos related to
Sort By:
Pageof 14
Digestive Diseases and Sciences|March 10, 2009
Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experienceHiroto Egawa, Kaoru Taira, Satoshi Teramukai, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 19, 2019
Use of Nakanuma staging and cytokeratin 7 staining for diagnosing recurrent primary biliary cholangitis after living-donor liver transplantationNoriyo Yamashiki, Hironori Haga, Yoshihide Ueda, et al.Scientific Reports|April 1, 2017
Evolution of multi-drug resistant HCV clones from pre-existing resistant-associated variants during direct-acting antiviral therapy determined by third-generation sequencingHaruhiko Takeda, Yoshihide Ueda, Tadashi Inuzuka, et al.Hepatology Communications|February 27, 2023
Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencingSoichi Arasawa, Haruhiko Takeda, Atsushi Takai, et al.Journal of Gastroenterology and Hepatology|August 31, 2002
Primary hepatic carcinoid tumor with metachronous lymph node metastasis after long-term follow upYuji Iimuro, Yasunori Deguchi, Yoshihide Ueda, et al.Internal Medicine (Tokyo, Japan)|April 8, 2010
Spontaneous rupture of liver plasmacytoma mimicking hepatocellular carcinomaKosuke Ueda, Hiroyuki Matsui, Tomohiro Watanabe, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|October 20, 2022
Constitution of mucosa-associated microbiota in the lower digestive tract does not change in early stage of non-alcoholic fatty liver disease with fecal dysbiosisNaoki Asaji, Jun Inoue, Hiroki Hayashi, et al.Internal Medicine (Tokyo, Japan)|August 28, 2018
Accelerated Progression of Hepatocellular Carcinoma during Immunosuppressive Therapy with Abatacept for Rheumatoid ArthritisSatoshi Yoshiji, Ken Takahashi, Kenji Sawada, et al.Diagnostics (Basel, Switzerland)|April 26, 2024
Risk Factors for Immune Checkpoint Inhibitor-Induced Liver Injury and the Significance of Liver BiopsyMiki Kawano, Yoshihiko Yano, Atsushi Yamamoto, et al.Journal of Gastroenterology|November 23, 2011
Decrease in alpha-fetoprotein levels predicts reduced incidence of hepatocellular carcinoma in patients with hepatitis C virus infection receiving interferon therapy: a single center studyYukio Osaki, Yoshihide Ueda, Hiroyuki Marusawa, et al.Pageof 14